Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2269968
Max Phase: Preclinical
Molecular Formula: C23H32ClN3O4
Molecular Weight: 449.98
Molecule Type: Small molecule
Associated Items:
ID: ALA2269968
Max Phase: Preclinical
Molecular Formula: C23H32ClN3O4
Molecular Weight: 449.98
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCc1nn(C)c(C(=O)N(CCOc2ccc(CCOCC)cc2C)C(C)=O)c1Cl
Standard InChI: InChI=1S/C23H32ClN3O4/c1-6-8-19-21(24)22(26(5)25-19)23(29)27(17(4)28)12-14-31-20-10-9-18(15-16(20)3)11-13-30-7-2/h9-10,15H,6-8,11-14H2,1-5H3
Standard InChI Key: SJUNUUWEMKMDOM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 449.98 | Molecular Weight (Monoisotopic): 449.2081 | AlogP: 3.98 | #Rotatable Bonds: 11 |
Polar Surface Area: 73.66 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 1.20 | CX LogP: 3.94 | CX LogD: 3.94 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.48 | Np Likeness Score: -0.88 |
1. OBATA T, FUJII K, FUNAKI E, TSUTSUMIUTI K, OHOKA A, SUIZU S, KANETSUKI Y. (1999) Synthesis and Selective Bioactivity of New Pyrazolecarboxamide Derivatives, 24 (1): [10.1584/jpestics.24.33] |
Source(1):